SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 97 filers reported holding SYNAGEVA BIOPHARMA CORP in Q3 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $103,262,000 | +18.5% | 1,058,768 | +12.7% | 0.02% | +13.6% |
| Q4 2014 | $87,162,000 | +45.9% | 939,346 | +8.1% | 0.02% | +29.4% |
| Q3 2014 | $59,749,000 | -34.2% | 868,703 | +0.3% | 0.02% | -34.6% |
| Q2 2014 | $90,789,000 | +21.9% | 866,311 | -3.5% | 0.03% | +18.2% |
| Q1 2014 | $74,454,000 | +38.3% | 897,356 | +7.9% | 0.02% | +37.5% |
| Q4 2013 | $53,848,000 | +14.1% | 832,021 | +11.8% | 0.02% | 0.0% |
| Q3 2013 | $47,175,000 | +75.3% | 744,178 | +16.1% | 0.02% | +60.0% |
| Q2 2013 | $26,913,000 | – | 641,098 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|